Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency

Platinum-based regimens have not been proved to increase survival from advanced prostate cancer (PCa). Incontrovertible evidence that a proportion of prostate cancers have homologous recombination DNA (HRD) repair defects, and that such genomic aberrations are synthetically lethal with both poly(ADP...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Eur Urol
Main Authors: Zafeiriou, Zafeiris, Bianchini, Diletta, Chandler, Robert, Rescigno, Pasquale, Yuan, Wei, Carreira, Suzanne, Barrero, Maialen, Petremolo, Antonella, Miranda, Susana, Riisnaes, Ruth, Rodrigues, Daniel Nava, Gurel, Bora, Sumanasuriya, Semini, Paschalis, Alec, Sharp, Adam, Mateo, Joaquin, Tunariu, Nina, Chinnaiyan, Arul M., Pritchard, Colin C., Kelly, Kevin, de Bono, Johann S.
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier Science 2019
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6291437/
https://ncbi.nlm.nih.gov/pubmed/30340782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2018.09.048
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים